| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.2 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.2 |